Abstract
Targeted anti-cancer therapies aim at reducing side effects while retaining their anti-cancer efficacy. Immunotherapies e.g. monoclonal antibodies, ad......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
